Clinical trial · Interventional
Study of the Anti-tumoral Immune Response
Study of the Anti-tumoral Immune Response T Cells Cluster of Differentiation 4 (TCD4): Proof of the Concept in Breast Cancer and Glioma
NCT02854644CI-TRIAL-00058838ERISAcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the frequency of the spontaneous T cells specific CD4 answers of tumoral antigens breast cancer and glioma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Glioma | Glioma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| additional blood sample | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- type
- EXPERIMENTAL
- label
- glioma
- description
- 1 additional blood sample for patients with glioma and without treatment
- interventionNames
- Other: additional blood sample
- type
- EXPERIMENTAL
- label
- breast cancer
- description
- 2 additional blood samples for patients with localized brest cancer, metastatic breast cancer in 1st line of treatment and breast cancer in second line of treatment.
- interventionNames
- Other: additional blood sample
- type
- EXPERIMENTAL
- label
- breast cancer HER2+
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Performance status 0,1 or 2 * breast cancer or glioma * Arm glioma: patients without anti-tumoral treatment * Arm breast cancer: inclusion before treatment * Arm breast cancer HER2: patients with current therapy Exclusion Criteria: * Psychiatric disease compromising the understanding of the information or the realization of the study * vulnerable People according to the law (minors, adults under protection, private persons of freedom ...) * Unaffiliated People to the Social Security * People being for the period of exclusion from another study * Life expectancy estimated unless 3 months. * For patients in Arm glioma: patients having already begun a systematic treatment. * For patients with a breast cancer: patient already under current therapy
References
Publications (0)
Data not yet available
No reference posted for this study.